These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6262145)

  • 1. Killed poliovaccine: an evaluation of safety testing.
    van Steenis G; van Wezel AL
    Dev Biol Stand; 1981; 47():143-50. PubMed ID: 6262145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of sensitivity of VERO cell line versus primary monkey kidney cells in the detection of residual live polio virus during and after inactivation.
    Montagnon BJ; Nicolas AJ; Fanget B; Peyron L
    Dev Biol Stand; 1981; 47():151-5. PubMed ID: 6262146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The production of inactivated poliovaccine on serially cultivated kidney cells from captive-bred monkeys.
    van Wezel AL; van der Velden-de Groot CA; van Herwaarden JA
    Dev Biol Stand; 1980; 46():151-8. PubMed ID: 6244995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell substrate for killed poliovaccine production.
    Beale AJ
    Dev Biol Stand; 1981; 47():19-23. PubMed ID: 6262147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The large-scale cultivation of VERO cells in micro-carrier culture for virus vaccine production. Preliminary results for killed poliovirus vaccine.
    Montagnon BJ; Fanget B; Nicolas AJ
    Dev Biol Stand; 1981; 47():55-64. PubMed ID: 6785126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The monitoring of antigen levels during inactivated poliovirus vaccine production: evaluation of filtration techniques.
    Moynihan M; Petersen I
    Dev Biol Stand; 1981; 50():243-8. PubMed ID: 6804290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potency testing of killed polio vaccine in rats.
    van Steenis G; van Wezel AL; Sekhuis VM
    Dev Biol Stand; 1981; 47():119-28. PubMed ID: 6262142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WHO activities towards the three Rs in the development and control of biological products.
    Milstien J; Grachev V; Padilla A; Griffiths E
    Dev Biol Stand; 1996; 86():31-9. PubMed ID: 8785961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proposals on the control of VERO cells used to prepare inactivated poliomyelitis vaccine.
    Ménetrat JL; Chaniot S; Lefrançois S; Canale A; Chippaux A
    Dev Biol Stand; 1981; 47():163-7. PubMed ID: 6785125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on new attenuated strains of type III live poliomyelitis vaccine. I. Development of a new type III attenuated poliovirus.
    Chin Med J (Engl); 1980 Sep; 93(9):583-90. PubMed ID: 6253236
    [No Abstract]   [Full Text] [Related]  

  • 11. Present state and developments in the production of inactivated poliomyelitis vaccine.
    van Wezel AL
    Dev Biol Stand; 1981; 47():7-13. PubMed ID: 6262162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Counterimmunoelectrophoresis of SV40 and its application in quality control and production of poliovaccine].
    Ye M
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1988 Feb; 10(1):64-7. PubMed ID: 2838191
    [No Abstract]   [Full Text] [Related]  

  • 13. CBER: new approaches to biological product testing.
    Donlon JA
    Dev Biol Stand; 1999; 101():21-5. PubMed ID: 10566770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potency testing for killed poliomyelitis vaccine.
    Beale AJ
    Dev Biol Stand; 1981; 47():69-75. PubMed ID: 6262161
    [No Abstract]   [Full Text] [Related]  

  • 15. Potency test of killed polio vaccines. Statistical analysis of test on chicken and preliminary results in combination with ELISA D-antigen determinations.
    Larbaigt G; Moulin J; Souvras M; Gibelin N; Beranger G
    Dev Biol Stand; 1981; 47():113-8. PubMed ID: 6262141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of animals in the development and control of viral vaccines.
    Minor PD
    Dev Biol Stand; 1996; 86():113-20. PubMed ID: 8785940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparisons of poliovirus antigen measurements in vitro and in small animals.
    von Seefried A; Bryce E; Campbell JB; Chun JH; Laurence GD; Scollard N; Tsai KS
    Dev Biol Stand; 1981; 47():91-100. PubMed ID: 6262165
    [No Abstract]   [Full Text] [Related]  

  • 18. Karyological characterization of WI-38 cells used in the production of vaccines.
    Frieling KH; Hövel H
    Dev Biol Stand; 1976 Dec 13-15; 37():181-4. PubMed ID: 1031684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of new approaches to poliovirus vaccine neurovirulence tests.
    Wood DJ
    Dev Biol Stand; 1996; 86():79-83. PubMed ID: 8785995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of different immunisation schedules on the excretion and reversion of oral poliovaccine strains.
    Minor PD; Dunn G; Ramsay ME; Brown D
    J Med Virol; 2005 Jan; 75(1):153-60. PubMed ID: 15543587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.